PHARMACY

SB 159 authorizes pharmacists to prescribe PrEP and PEP to patient without a physician prescription and prohibits insurance companies from requiring patients to obtain prior authorization before using their insurance benefits to obtain PrEP or PEP.

Tecfidera capsules, 120 mg and 240 mg had a market value of approximately $3.7 billion for the 12 months ended in August 2019.

Paliperidone extended-release tablets had a market value of approximately $373 million for the 12 months ended July 31.

Genoa Healthcare is celebrating the recent opening of several new pharmacies across seven states.

Eli Lilly's Reyvow is a new option for the acute treatment of migraine.

DSN found some of the many pharmacists who do more than asked. Here are their stories.

Pharmacy consultant and industry expert Bruce Kneeland takes a look at an independent PBM business model focused on saving money and improving patient outcomes.

The FDA has approved Zydus Cadila's generic cholesterol-lowering drug.

Alembic Pharmaceuticals is introducing its first ophthalmic glaucoma product.

Roche's Rituxan now is the first and only FDA approved treatment for pediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis.

As American Pharmacists Month kicks off, Walgreens is recognizing the roughly 75,000 pharmacists and pharmacy technicians it employs for their work in health and patient care.

The divestiture of Rhofade is a key component of Aclaris’ recently announced strategic plan to refocus resources on the development of its immuno-inflammatory development programs.